Share on

Global Genome Editing Market Size, Share, Trends, COVID-19 Impact and Growth Analysis Report – Segmented By Application, Technology, End-User and Region - Industry Forecast (2022 to 2027)

Published: January, 2022
ID: 2669
Pages: 175
Formats: report pdf report excel report power bi report ppt

Genome Editing Market Size (2022 to 2027)

As per our analysis report, the global genome editing market is estimated to be USD 4.24 billion in 2022 and is expected to be growing at a CAGR of 14.42%, to reach USD 8.33 billion by 2027.

Genome editing is the procedure of gene modification through recombinant DNA technology, which decreases cell toxicity and increases accuracy. Genomic editing stated the techniques and strategies executed to modify target any living organism for their genetic information. Genome editing may lead to the development of progressive medical treatments, the handling of genes that contribute to diseases, improving the quality of agricultural products, and more.


The rise in government funding for genomic research, an increase in R&D expenditure, growth in the production of genetically modified crops, and technological advancements are majorly driving the global genome editing market growth.

The major companies have made substantial investments in research and development to develop CRISPR and TALEN technologies. Genome editing applications include therapeutic genetic editing as well in infected cells and tissues, thereby removing dangerous mutations, disruption of viral DNA, and therapeutic transgenes. It also plays a pivotal role in the future development of stem cell engineering and gene therapy. Additionally, antiviral applications for treating uncured diseases such as HIV, herpes, and hepatitis B are also under research.

The global genome editing market is further progressing due to the more significant number of application areas such as therapeutics, mutation and agriculture, and biotechnology. These technologies offer many openings in crop improvement in gene-targeted exchange therapy, which is not yet grasped. For crop improvements, homologous recombination is an effective procedure and expected to drive the global genomic editing market in the future. The scope of the genomic editing market is rising due to the number of increasing applications and diseases. Genome editing has a substantial range to treat a diversity of cancers, genetically affected cells, and agents of infectious diseases such as parasites, viruses, bacteria, etc.

Increasing focus of government and private organizations to invest in research and developments of genome editing, rising number of applications in therapeutics, agriculture biotechnology, and mutation fields, and to treat genetically affected cells and various infections are likely to provide lucrative opportunities for the growth of the global genome editing market over the forecast period.


The significant factors affecting the genome editing market include the increasing use of genetically modified crops and the technological advancements in the field. The willingness of the government to provide ample funding for further research and development in the area is yet another booster to the market growth. Even though the market is expected to grow vastly in the future years, it is hampered by factors such as the high costs associated with genomic equipment and ethical concerns regarding modifying an organism’s DNA.

Ethical issues related to the crops genomic editing and others are hampering the market growth. The concerns for animal welfare can rise at all phases of generation, and the life duration of genetically engineered animals hinders the global genome editing market.

Impact of COVID-19 on the global genome editing market:

SARS-COV-2 was first identified, and it was declared as a global pandemic. Numerous disciplines such as drug development, human genome engineering, and genome editing technology are being used against COVID-19 disease. Many researchers directed their research to study the novel virus and the disease it causes. The World Health Organization created solidary, global clinical trials, which are being tested four drugs as a possible treatment. The genome-editing tool has been brought to the frontlines in combat with COVID-19. They are programming the CRISPR systems through the COVID-19 test kit to detect the signature of SARS-CO-2.  CRISPR- Cas systems have been designed to combat the COVID-19.

Scientists have been using CRISPR technology to develop rapid diagnostic tests for SARS-COV-2. Scientists are looking at CRISPR as a potential therapeutic utilized in targeted enzymatic activity to destroy the coronavirus RNA and prevent virus replication. Technology-based gene-editing systems play a vital role in defense against the infection. Hence the market has gained a positive impact in fighting against the COVID-19, and the genome editing market growth is projected to rise in the coming years.




Market Size Available

2021 to 2027

Base Year


Forecast Period

2022 to 2027

Segments Covered

By Application, Technology, End-User, and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, Asia Pacific, Latin America, Middle East, and Africa


This research report on the global genome editing market has been segmented and sub-segmented into the following categories and analyzed market size and forecast to each segment until 2027.

Global Genome Editing Market – By Application:

  • Cell Line Engineering          
  • Animal Genetic Engineering           
  • Plant Genetic Engineering

Based on application, the cell line engineering segment is ruling the market and is expected to grow with the increasing CAGR during the forecast period. Increasing demand for stem cell therapies, intensifying focus of key players on stem cell research, and growing funds from private and public sectors are the major factors contributing to the growth of the cell line engineering segment, leading to a boost of the genome editing market.

Global Genome Editing Market – By Technology:

  • ZFN
  • Antisense
  • Other Technologies

Based on technology, the CRISPR segment contributes a significant share of revenues to the market. It is likely to grow further during the forecast period due to its ability to target multiple sites simultaneously in a single cell using various guide RNAs.

Global Genome Editing Market – By End-users:

  • Biotechnological & Pharmaceutical Companies
  • Academic and Government Research Institutes
  • Contract Research Organizations

Based on end-users, the Academic and research institutes segment dominates the market due to government initiatives and funding for research in stem cell therapies and genetic engineering. The emergence of new pharmacy and biotech companies in developing countries is boosting the growth of the Pharmaceutical and biotechnological segment.

Global Genome Editing Market – By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • The Middle East and Africa

Regionally, the global genome editing market was dominated by North America in 2019, with the region accounting for 40% of the overall market share. North America was followed next in line by Europe and Asia-Pacific.

North America is likely to continue its existence in the global genome editing market due to the high funding given by the governments for genomic modification in the region. North America is holding the largest market share in the genome editing market, followed by Asia-Pacific and Europe region, and also it is having a higher patients count. Acceptance of government funding and research grants, GM crop adoption, and development in gene therapy anticipates the growth of the genome editing market in North America. 

Asia-Pacific is expected to grow rapidly in the coming years, as is evident from the high CAGR value for the region. Another promising area for the market in Latin America, which is expected to show high growth rates in the coming years. The Asia Pacific has a steady growth in the market for the past few years due to the upsurge in investments by essential players in the region. The rise in government initiatives to funding the start-up companies and new players in the pharmaceutical and biotechnology industries and the increase in drug discovery and development activities are the major factors anticipated to drive the genome editing market growth in the Asia Pacific region during the forecast period.


Noteworthy companies operating in the global genome editing market profiled in this report are Thermo Fisher ScientificMerck KGAA, Horizon Discovery Group Plc, Genscript Biotech CorporationSangamo BiosciencesIntegrated DNA Technologies, Lonza Group Ltd, New England Biolabs, Origene Technologies, and Transposagen Biopharmaceuticals.


  • REMD Biotherapeutics Company collaborated with GenScript Biotech Corporation in 2019. This alliance is focused on developing biospecific antibodies.  
  • Thermo fisher scientific has developed a new assay called Ion Torrent Oncomine Myeloid Research Assay, which runs on Ion Torrent Genexux System, and it will be available from 2020.

Please wait. . . . Your request is being processed

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2500

Didn’t find what you’re looking for?

Need something within your budget?


Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us:

Click for Request Sample